.Avidity Biosciences pleased entrepreneurs along with phase 1/2 data in Duchenne muscle dystrophy (D...
.Actinogen Medical's cortisol blocker has missed the major endpoint of a phase 2 study in clinical d...
.Antibody-drug conjugates (ADCs) have gone to the center of lots of a billion-dollar biobuck licensi...
.Property manager TPG, which has assisted biotechs including Sionna Therapies as well as Santa Ana B...
.Merck & Co.'s TIGIT program has suffered an additional obstacle. Months after shuttering a phase...
.After a year determined through pipe cuts, the shift of its CEO and discharges, Exscientia will def...
.Cullinan Therapy was actually impressed good enough with Port BioMed's bispecific immune system act...
.In this week's incident of "The Top Line," our team are actually diving right into Fierce Biotech's...
.The confetti is still soaring coming from Eli Lilly's celebration commemorating the commendation of...
.Accept to this week's Chutes & Ladders, our roundup of considerable management hirings, shooting...